Facebook Linkedin Mail Twitter
Facebook Linkedin Mail Twitter
    Latest

    Structural Heart

    AccuCinch ventricular repair system

    AccuCinch ventricular repair system associated with favourable safety profile at 30...

    AtriCure agrees to buy LARIAT developer SentreHEART

    atrial fibrillation ablation

    ESC 2019: Left atrial appendage closure is non-inferior to NOACS for...

    global registry of HVAD thoracotomy implants announced by Medtronic

    Medtronic announces global registry of HVAD thoracotomy implants

    CE mark for the FEops HEARTguide

    BioCardia submits 510(k) application to US FDA for its Avance steerable...

    Presence of left bundle branch block significantly increases risk of pacemaker...

    US FDA plan shakeup of its 510(k) clearance programme

    Atrial fibrillation related to PFO closure occurs early and is transient

    Patients with new-onset atrial fibrillation after TAVI have highest risk of...

    Simultaneous TAVI and left atrial appendage closure is feasible

    Novel Ultraseal device is a feasible option for left atrial appendage...

    Boston Scientific to buy cerebral protection system company

    PREVAIL watchman

    TCT 2017: Boston Scientific reveals presentations at conference

    Three studies support efficacy of PFO closure for reducing risk of...

    US trial to evaluate safety and efficacy of Amplatzer for patent...

    CSI 2017: Global postmarket surveillance study to explore use of LAmbre...

    Load more

    Most read

    Features

    Profiles

    Athena Poppas

    Eric Prystowsky

    Eric N Prystowsky

    Pedro Brugada

    Cardiac Rhythm News

    Write to us
    Editor: Jamie Bell [email protected]
    Advertising: Hannah Shiels [email protected]


    United Kingdom:

    BIBA Medical, Europe
    526 Fulham Road, Fulham, London, SW6 5NR
    TEL: +44 (0)20 7736 8788
    Email: [email protected]

    United States:

    BIBA Medical, North America
    155 North Wacker Drive, Suite 4250, Chicago, IL 60606
    TEL: +1 949 723 9309
    Email: [email protected]

    Terms and Conditions | Privacy Policy

    Facebook Linkedin Mail Twitter